A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
April 17, 2012
April 10, 2012
A new technique for analyzing brain images offers the possibility of using magnetic resonance imaging (MRI) to predict the rate of progression and physical path of many degenerative brain diseases, report scientists at the San Francisco VA Medical Center and the University of California, San Francisco.
April 03, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have enhanced the understanding of how a protein linked to Alzheimer’s disease keeps young brains healthy, but can damage them later in life — suggesting new research avenues for treating this devastating disease.
March 21, 2012
A new study raises hopes that physicians may be able to use MRI to predict the course of dementias and that researchers may use these predicted outcomes to determine whether a new treatment is working.
March 15, 2012
A group of scientists at UCSF has discovered that a tiny molecule in the fly’s brain govern the behavior of males who go on a drinking binge after female fruit flies reject their sexual advances.
March 14, 2012
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
February 28, 2012
Neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, participated in a roundtable discussion on Alzheimer’s disease and frontotemporal dementia on the "Charlie Rose Show."
February 15, 2012
A major clinical trial conducted with patients experiencing a prolonged convulsive seizure has shown that injecting drugs into the thigh muscle is just as safe and more effective than giving the medication intravenously.
January 30, 2012
Richard K. Olney, MD, founding director of the ALS Treatment and Research Center at UCSF and a pioneer in clinical research on amyotrophic lateral sclerosis (ALS), has died at age 64, following his own eight-year battle with the disease.
January 25, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have identified a protein that exacerbates symptoms of Parkinson’s disease — a discovery that could one day lead to new treatments for people who suffer from this devastating neurodegenerative illness.